IVL 7002
Alternative Names: APB-G001; IVL-7002Latest Information Update: 06 Feb 2023
At a glance
- Originator Inventage Lab
- Class Antibodies; RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Unspecified
Most Recent Events
- 01 Dec 2022 Inventage Lab and APITBIO enters into a R&D agreement for the development of IVL 7002 (Inventage Lab pipeline, December 2022)
- 01 Dec 2022 Investigation in Unspecified in South Korea (Parenteral), prior to December 2022 (Inventage Lab pipeline, December 2022)